BioCentury
ARTICLE | Clinical News

Live tumor cell diagnostic: Pilot trial data

July 20, 2015 7:00 AM UTC

A blinded analysis of 104 tumor tissue samples obtained from radical prostatectomies from a U.S. proof-of-concept (POC) trial showed that Cellanyx’s live tumor cell phenotypic biomarker test had 88% s...